Back to Search
Start Over
All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: Commentary.
- Source :
-
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2022 Sep; Vol. 28 (10), pp. 1502-1503. Date of Electronic Publication: 2022 May 12. - Publication Year :
- 2022
- Subjects :
- Humans
Protein Kinase Inhibitors adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1477-0970
- Volume :
- 28
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Multiple sclerosis (Houndmills, Basingstoke, England)
- Publication Type :
- Academic Journal
- Accession number :
- 35546510
- Full Text :
- https://doi.org/10.1177/13524585221097562